Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Methadone or buprenorphine preferred over naltrexone by inmates | Synapse

September 27, 2024

View Full Paper

Methadone or buprenorphine preferred over naltrexone by inmates

AKAlison KnopfUniversity of Southern California

Key Points

Key points are not available for this paper at this time.

Abstract

When CODAC Behavioral Healthcare, the main provider of treatment services for corrections in Rhode Island, looks at its clientele with opioid use disorder (OUD), Vivitrol (depot naltrexone) is preferred by no one. The patients want either methadone or buprenorphine, CODAC CEO Linda Hurley explained in a webinar this month (for the first part of this two‐part article, see ADAW ( https://onlinelibrary.wiley.com/doi/10.1002/adaw.34254 ).

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Alison Knopf (Fri,) studied this question.

synapsesocial.com/papers/68e5742cb6db643587513fd1 https://doi.org/https://doi.org/10.1002/adaw.34262

Ask AI

Helpful

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients2024 · 11 citations
2Methadone compared to buprenorphine2024
3Going from theory to practice: Succeeding with OTPs in corrections2024
4Naltrexone Treatment for Methamphetamine Dependence – Service Evaluation Audit2024
5Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment2026